Results 181 to 190 of about 67,148 (238)

Neonatal fungemia: a case series highlighting the threat posed by non-albicans Candida (NAC) species and a yeast-like filamentous fungus. [PDF]

BMC Infect Dis
Soni R, Jadi R, Kumar Sharma A, Singh Multani K.   +3 more
europepmc   +1 more source

<i>Aeromonas</i> spp. as possible bacterial indicator for monitoring antibiotic resistance in seafood. [PDF]

Front Microbiol
Albini E, Caponi B, Pieralisi S, Orsini S, Blasi F, Massaccesi L, Maresca C, Scoccia E, Fiorucci A, Michelacci V, Chiani P, Marra M, Carollo M, Massacci FR, Pezzotti G, Leoni F, Magistrali CF.   +16 more
europepmc   +1 more source

Transfer of a blaTEM-52 -carrying plasmid from an E. coli isolate from broilers to human E. coli strains, in an in vitro continuous flow culture system, simulating the human caecum and the ascending colon [PDF]

, 2009
Butaye, Patrick, Dewulf, Jeroen, Haesebrouck, Freddy, Herman, Lieve, Heyndrickx, Marc, Martel, An, Persoons, Davy, Rasschaert, Geertrui, Smet, Annemieke   +8 more
core  

Longitudinal trends in antibiotic resistance of <i>Escherichia coli</i>: A 10-years retrospective analysis in a tertiary care hospital in Lahore, Pakistan. [PDF]

Pak J Med Sci
Fayyaz A, Iqbal MD, Ghafoor F.
europepmc   +1 more source

Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain. [PDF]

Antimicrob Agents Chemother
Llorente J, Sempere J, Llamosí M, Pérez-García C, Úbeda A, Vidal-Alcántara EJ, Sanz JC, Domenech M, Yuste J.   +8 more
europepmc   +1 more source

Polyphenols as Potential β-Lactamase Inhibitors: An Integrated Computational and Experimental Study. [PDF]

Molecules
Mourabiti F, Jouga F, Calvo LG, Villarino RA, Zouheir Y, Soukri A, de Miguel T, El Khalfi B.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cefotaxime

Reactions Weekly, 2010
Cefotaxime is a third-generation or extended-spectrum cephalosporin which was developed in the 1970s and approved by the US Food and Drug Administration (FDA) in 1981. Cefotaxime is (6R,7R)-3-(acetyloxymethyl)-7- [[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid; its formula is
Kim, Baek-Nam, Paterson, David L.
openaire   +2 more sources